- Home
- BLCO vs FFIN Comparison
BLCO vs FFIN Comparison
Compare BLCO & FFIN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BLCO
- FFIN
- Stock Information
- Founded
- BLCO 1853
- FFIN 1890
- Country
- BLCO Canada
- FFIN United States
- Employees
- BLCO N/A
- FFIN N/A
- Industry
- BLCO Ophthalmic Goods
- FFIN Major Banks
- Sector
- BLCO Health Care
- FFIN Finance
- Exchange
- BLCO Nasdaq
- FFIN Nasdaq
- Market Cap
- BLCO 6.3B
- FFIN 5.8B
- IPO Year
- BLCO 2022
- FFIN N/A
- Fundamental
- Price
- BLCO $15.77
- FFIN $36.83
- Analyst Decision
- BLCO Buy
- FFIN Hold
- Analyst Count
- BLCO 12
- FFIN 4
- Target Price
- BLCO $19.82
- FFIN $40.25
- AVG Volume (30 Days)
- BLCO 751.8K
- FFIN 448.2K
- Earning Date
- BLCO 02-19-2025
- FFIN 04-17-2025
- Dividend Yield
- BLCO N/A
- FFIN 1.96%
- EPS Growth
- BLCO N/A
- FFIN 12.23
- EPS
- BLCO N/A
- FFIN 1.56
- Revenue
- BLCO $4,791,000,000.00
- FFIN $536,909,000.00
- Revenue This Year
- BLCO $17.29
- FFIN N/A
- Revenue Next Year
- BLCO $5.47
- FFIN $4.62
- P/E Ratio
- BLCO N/A
- FFIN $23.61
- Revenue Growth
- BLCO 15.56
- FFIN 11.58
- 52 Week Low
- BLCO $13.16
- FFIN $27.62
- 52 Week High
- BLCO $21.69
- FFIN $44.66
- Technical
- Relative Strength Index (RSI)
- BLCO 32.89
- FFIN 44.60
- Support Level
- BLCO $15.62
- FFIN $35.89
- Resistance Level
- BLCO $16.60
- FFIN $37.90
- Average True Range (ATR)
- BLCO 0.46
- FFIN 1.08
- MACD
- BLCO -0.05
- FFIN -0.07
- Stochastic Oscillator
- BLCO 7.01
- FFIN 34.31
About BLCO Bausch + Lomb Corporation
Bausch & Lomb is one of the largest vision care companies in the US. The firm was previously a subsidiary under parent company Bausch Health and it was spun off to become a public company in 2022. It operates in three segments: vision care, surgical, and ophthalmic pharmaceuticals. Vision care is composed of contact lenses, a market that B&L controls 10%, and ocular health products, which includes Biotrue and Lumify. Surgical includes a suite of intraocular lenses, equipment for cataract and vitreoretinal surgeries, as well as surgical instruments. Ophthalmic pharmaceuticals has a diverse lineup of products, including Xipere, Vyzulta, and Lotemax that treat different complications. With over 100 products, B&L has the largest portfolio of eye care prescriptions in the space.
About FFIN First Financial Bankshares Inc.
First Financial Bankshares Inc is a financial and bank holding company. The company operates one line of business (community banking) located in a single geographic area (Texas). The company conducts a full-service commercial banking business through its subsidiaries. The loan portfolio segments of the company include Commercial and Industrial, Municipal, Agricultural, Construction and Development, Farm, Non-Owner Occupied and Owner Occupied Commercial Real Estate, Residential, Consumer Auto and Consumer Non-Auto.